Patent-family-83692885

Patent Number: CN-118251397-A

Publication Year: 2024

Application Year: 2022

Priority Year: 2021

Jurisdictions: CN

Status: Pending

Inventors:

T. Jensen M. Jessin YU WANWAN D. R. Diaz J NILSSON C.R. JONES T. Anderson M.F. Jacobson

Applicants:

  1. Lundbeck (Denmark)
    2. [NORA names: Lundbeck; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention relates to compounds of formula I. These compounds are believed to be useful in the treatment of LRRK 2-associated diseases, such as parkinson's disease.

Patent Family Records (1)

LRRK2 inhibitors

H Lundbeck AS, Lundbeck (Denmark) T. Jensen, M. Jessin, YU WANWAN, (...more)

2024, CN-118251397-A

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link